The economic evaluation of personalised oncology medicines: ethical challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The economic evaluation of personalised oncology medicines: ethical challenges

Published:2013-10 Issue:7 Volume:199 Page:471-473
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Lewis Jan R R¹,Lipworth Wendy L²,Kerridge Ian H¹,Day Richard O³

Affiliation:

1. Centre for Values, Ethics and Law in Medicine, University of Sydney, Sydney, NSW.

2. Australian Institute of Health Innovation, University of New South Wales, Sydney, NSW.

3. Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, NSW.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja13.10046

Reference25 articles.

1. Optimizing First-Line Treatment Options for Patients with Advanced NSCLC

2. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease

3. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

4. Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

5. First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration;BMJ Open;2020-01

2. First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013;Haematologica;2018-11-22

3. The Future of Precision Medicine: Potential Impacts for Health Technology Assessment;PharmacoEconomics;2018-07-13

4. Use of Real-World Data for the Research, Development, and Evaluation of Oncology Precision Medicines;JCO Precision Oncology;2017-11

5. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer;Molecular Oncology;2017-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3